Data work in 2026 asks for more than chart building. Professionals are expected to clean data, query databases, explain ...

The Indian Institute of Science has announced an online course on machine learning for 6G wireless communication under its Centre for Continuing Education (CCE). The programme is scheduled to run from ...

“Python’s Kiss” collects a baker’s dozen stories, nine of which previously have been published in the New Yorker and elsewhere (each is illustrated with a drawing by the author’s daughter, Aza Erdrich ...

In my Boston Globe review of Louise Erdrich’s 2016 novel “LaRose,” I described her as “an artist of the liminal.” “Python’s Kiss,” Erdrich’s new collection of stories written over 20 years, testifies ...

Never miss a story with The Brief, our free newsletter. Independent Texas reporting needs your support. Help us bring you and millions of others in-depth news and information. Will you join our ...

Bottom Line: Why Choose UWorld? After spending time inside the platform, UWorld feels the most dialed in for serious ACT repetition and mistake analysis. It keeps everything centered on practice ...

Inland Northwest golfers can start retrieving their clubs from winter storage. Spokane County Parks, Recreation and Golf intends to open its three county-owned courses in the coming weeks, following a ...

The Dell XPS 14 brings the company’s flagship laptop back into competition with speedy Intel Core Series 3 chips and a redesign that’s more practical, yet still premium. In 2022, Dell took a big swing ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. According to recent data ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.